2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)

ESC Sci Document Grp, Alexander R. Lyon, Teresa Lopez-Fernandez, Liam S. Couch, Riccardo Asteggiano, Marianne C. Aznar, Jutta Bergler-Klein, Giuseppe Boriani, Daniela Cardinale, Raul Cordoba, Bernard Cosyns, David J. Cutter, Evandro de Azambuja, Rudolf A. de Boer, Susan F. Dent, Dimitrios Farmakis, Sofie A. Gevaert, Diana A. Gorog, Joerg Herrmann, Daniel LenihanJavid Moslehi, Brenda Moura, Sonja S. Salinger, Richard Stephens, Thomas M. Suter, Sebastian Szmit, Juan Tamargo, Paaladinesh Thavendiranathan, Carlo G. Tocchetti, Peter van der Meer, Helena J. H. van der Pal

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article numberjeac106
Number of pages133
JournalEuropean heart journal-Cardiovascular imaging
DOIs
Publication statusE-pub ahead of print - 26-Aug-2022

Keywords

  • Guidelines
  • Androgen deprivation therapy
  • Anthracycline
  • Atrial fibrillation
  • Arrhythmias
  • Biomarkers
  • Cancer
  • Cancer survivors
  • Carcinoid syndrome
  • Amyloid light-chain cardiac amyloidosis
  • Cardiac magnetic resonance
  • Cardiac tumour
  • Cardio-oncology
  • Cardiotoxicity
  • Coronary artery disease
  • Chemotherapy
  • Echocardiography
  • Fluoropyrimidine
  • Heart failure
  • Haematopoietic stem cell transplantation
  • Hormone therapy
  • Hypertension
  • Immunotherapy
  • Ischaemic heart disease
  • Myocarditis
  • Pericardial disease
  • Pulmonary hypertension
  • Thrombosis
  • Risk stratification
  • Trastuzumab
  • Valvular heart disease
  • Vascular endothelial growth factor inhibitors (VEGFi)
  • Venous thromboembolism
  • Proteasome inhibitors
  • QTc prolongation
  • Radiotherapy
  • Strain
  • IMMUNE CHECKPOINT INHIBITORS
  • BRAIN NATRIURETIC PEPTIDE
  • CARCINOID HEART-DISEASE
  • CORONARY-ARTERY-DISEASE
  • EARLY BREAST-CANCER
  • RECURRENT VENOUS THROMBOEMBOLISM
  • TYROSINE KINASE INHIBITOR
  • MOLECULAR-WEIGHT HEPARIN
  • AORTIC-VALVE-REPLACEMENT
  • T-CELL THERAPY

Cite this